Key result
Adverse left atrial minimum and maximum volume remodelling following STEMI were associated with a higher risk of major adverse cardiac events (P=0.030 and P=0.018).
Why the study?
Is left atrial remodelling associated with major adverse cardiac events in patients following STEMI?
RCT (n=160)
Is left atrial remodelling associated with major adverse cardiac events in patients following STEMI?
Adverse left atrial remodelling following STEMI is driven by infarct size and is associated with an unfavorable long-term prognosis.
Answers are grounded in this paper and cite their sources.
LA remodelling may aid post-STEMI risk stratification; hypothesis-generating for targeted interventions.
PURPOSE: Left atrial (LA) volume is a strong prognostic predictor in patients following ST-segment elevation myocardial infarction (STEMI). However, the change in LA volume over time (LA remodelling) following STEMI has been scarcely studied. We sought to identify predictors for LA remodelling and to evaluate the prognostic importance of LA remodelling. METHODS: This is a subgroup analysis from a randomised clinical trial that evaluated the cardioprotective effect of exenatide treatment. A total of 160 patients with STEMI underwent a cardiovascular MR (CMR) 2 days after primary angioplasty and a second scan 3 months later. LA remodelling was defined as changes in LA volume or function from baseline to 3 months follow-up. Major adverse cardiac events were registered after a median of 5.2 years. RESULTS: Adverse LA minimum volume (LAmin) remodelling was correlated to the presence of hypertension, larger infarct size by CMR, higher peak troponin T, larger area at risk and adverse left ventricular (LV) remodelling. LA maximum volume (LAmax) remodelling was correlated to larger infarct size by CMR, higher peak troponin T, larger area at risk, larger LV mass, impaired LV function and adverse LV remodelling. Kaplan-Meier and Log Rank analyses showed that patients in the highest tertiles of LAmin or LAmax remodelling are at higher risk (0.030 and p=0.018). CONCLUSIONS: After a myocardial infarction, LA remodelling reflects a parallel ventricular-atrial remodelling. Infarct size is a major determinant of LA remodelling following STEMI and adverse LA remodelling is associated with an unfavourable prognosis.
No takes yet. Share an insight, caveat, or question.
Kyhl et al. (2015) conducted an RCT in ST-segment elevation myocardial infarction (STEMI) (n=160). Exenatide was evaluated on Major adverse cardiac events (p=0.030 and 0.018). Adverse left atrial minimum and maximum volume remodelling following STEMI were associated with a higher risk of major adverse cardiac events (P=0.030 and P=0.018).
Synapse has enriched 10 related papers. Consider them for comparative context: